Oral pharmaceutical formulations and methods for producing and using same
作者： Gregg A. Timony , Edgar H. Ulm , Robert K. Mansfield
DOI:
关键词:
摘要: Oral pharmaceutical formulations and methods of producing using the same are described claimed. The dispersions phospholipids one or more pharmacologically active compounds, In preferred embodiments, pharmaceutically compounds ansamycins, acceptable salts, prodrugs thereof.
google.co.uk 参考文章(21)
Fumio Shimojo, Masahiro Tsuji, Hiromitu Yoshida, Hideki Ito, Aerosol composition containing middle-chain fatty acid triglyceride dispersant ,(1997)
Alan J. Hutchison, Kenneth R. Shaw, Josef A. Schneider, Certain phosphonic acid quinoline-2-carboxylic acids, esters or amides useful for treatment of disorders responsive to N-methyl D-aspartate receptor blockade ,(1991)
Minori Okita, Katsumi Yamanaga, Hiroshi Shinyama, Hideaki Kido, Yuji Narita, Yoshiji Kubo, Takeshi Uchida, Masahiro Watanabe, Feng Wang, Koichi Yamanouchi, Kazutaka Hayashi, Norifumi Nakamura, Toru Kawamura, Masahide Nakajima, Pharmaceutical use of dihydropyridine derivative ,(1994)
Francis J. Burrows, Adeela Kamal, Marcus F. Boehm, Lin Zhang, Cytotoxins and diagnostic imaging agents comprising hsp90 ligands ,(2003)
B. Rao Vishnuvajjala, Edward A. Sausville, Melinda G. Hollingshead, Kenneth M. Snader, Geldanamycin derivative and method of treating cancer using same ,(2002)
Andrew Stephen Tomcufcik, John Paul Dusza, Jay Donald Albright, Aryl and heteroaryl[7-(aryl and heteroaryl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones ,(1984)
Neal Rosen, Mary Srethapakdi, Methods for treating cell proliferative disorders and viral infections ,(2001)
Andrew Xian Chen, Low oil emulsion compositions for delivering taxoids and other insoluble drugs ,(2004)
Francis J. Burrows, Lawrence C. Fritz, Methods for treating genetically-defined proliferative disorders with hsp90 inhibitors ,(2002)
S. Esmail Tabibi, Emmanuel I. Ezennia, B. Rao Vishnuvajjala, Shanker Gupta, Water-insoluble drug delivery system ,(1999)